Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Jiangsu Hengrui Pharmaceuticals Co. Ltd.
July 18, 2025
Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Orphan Drug Designation
FDA orphan drug designation: treatment of gastric cancer
Disease Area:
Rare Diseases
Source
Scroll to Top